← Back to Search

TACUNA Program for Opioid Use Disorder (TACUNA Trial)

N/A

Waitlist Available

Led By Elizabeth D'Amico, PhD

Research Sponsored by RAND

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

be in the age range of 18-25

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a culturally-centered intervention to reduce opioid use among urban American Indian/Alaska Native adults in California, compared to an opioid education workshop. The study will collect survey data from participants at different intervals to measure the effects of the intervention on opioid use and other outcomes.

Who is the study for?

This trial is for American Indian/Alaska Native individuals aged 18-25 who do not require substance treatment. It aims to help urban AI/AN young adults in California reduce opioid, alcohol, and other drug use through culturally centered interventions.

What is being tested?

The study compares two groups: one receiving TACUNA plus a Wellness Circle focusing on traditional practices and social networks, and the other attending an opioid education workshop tailored to the AI/AN community's needs.

What are the potential side effects?

Since this trial involves educational workshops and motivational interviewing rather than medical treatments or drugs, there are no direct side effects associated with these interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 25 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Frequency of alcohol and marijuana use

Frequency of opioid use

Secondary study objectives

Cultural connectedness

Network Composition

Network Structure

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: TACUNAExperimental Treatment1 Intervention

Randomized participants will attend 3 virtual TACUNA workshops, focused on behavioral, physical, and spiritual domains, and designed to guide AI/AN youth to make healthy choices surrounding opioid and AOD use. They will also attend a Wellness Circle, focused on healthy social networks and engaging in traditional practices.

Group II: Opioid educationActive Control1 Intervention

Randomized participants will attend 1 virtual opioid education workshop, focused on behavioral and physical domains, and designed to guide AI/AN youth to make healthy choices surrounding opioid and AOD use.

0 / 1Eligibility criteria met